| 07:30 |
Registration |
| 08:30 |
Session I: Opening
|
| |
08:30-08:35
Welcome to London and a New Approach to Disease Prevention
Julia Manning, Founding Director, 2020health, UK (Co-Chair)
08:35-08:50
Metabesity - 21st Century Solutions to a 21st Century Crisis
Professor Richard Barker, OBE, Founding Director of the Centre for the Advancement of Sustainable Medical Innovation (CASMI), UK
08:50-09:10
Metabesity—What, Why and How
Alexander Fleming, Executive Chairman and Founder, Kinexum, USA (Co-Chair)
09:10-09:50
It’s as much about Economics as Science
Joseph C. Cook, Jr., Executive Chairman and President, NuSirt BioPharma, USA
09:50-10:00
Overview of the Congress
Lawrence Steinman, George A. Zimmermann Professor and Professor of Pediatrics, Stanford University, USA (Co-Chair)
|
| 10:00 |
Session II: Metabesity Targets |
| |
Moderator: Alexander Fleming
10:00-10:25
Why Can’t I Prevent Obesity and Type 2 Diabetes?
Philip Home, Professor of Diabetes Medicine, Newcastle University, UK
|
| 10:25 |
Coffee Break, Networking and Poster Viewing
|
| 10:55 |
Session II: Metabesity Targets (continued)
|
| |
10:55-11:20
Common Inflammatory Pathways Associated with Degenerative Disease
Sir John Bell, Regius Professor of Medicine, Oxford University, UK
11:20-11:55
Exploiting Tumour Suppressive Mechanisms for Early Intervention in Cancer
Ashok Venkitaraman, Ursula Zoellner Professor of Cancer Research, University of Cambridge, and Director of the Medical Research Council (MRC) Cancer Unit, UK
11:55-12:20
NAD Metabolism and Aging
Eric Verdin, Buck Institute for Research on Aging, California, USA
12:20-12:30
Panel Discussion
|
| 12:30 |
Lunch Break, Networking and Poster Viewing
|
| 13:30 |
Session III: Approaches to Metabesity
|
| |
Moderator: Lawrence Steinman
13:30-13:50
Neuroinflammation - Using Big Data to Inform Clinical Practice
Lars Fugger, Weatherall Institute of Molecular Medicine, Oxford, UK
13:50-14:10
Interactions between Genetic, Lifestyle/Environmental Risk Factors for Multiple Sclerosis
Tomas Olsson, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
14:10-14:30
Glucose Metabolism and Dementia
Teresa Niccoli, University College London, UK
14:30-14:50
Metabesity and Dementia
Paul M. Matthews, OBE, MD, DPil, FRCP, FMedSci, Imperial College London, UK
14:50-15:10
Loneliness - A Major Risk Factor for and Target against Metabesity
Lucy Rose, MBA, Physician Assistant
President, Lucy Rose and Associates, LLC and Founder and President, The Cost of Loneliness Project
|
| 15:10 |
Coffee Break, Networking and Poster Viewing
|
| 15:40 |
Session III: Approaches to Metabesity (continued)
|
| |
15:40-16:00
What Have We Learned from the Diabetes Prevention Trials?
Itamar Raz, Head, Israeli National Council of Diabetes, Israel
16:00-16:20
Vitamin D and Obesity
Jenny Gunton, Chair of Medicine, University of Sydney, Westmead Hospital, Australia
16:20-16:30
Panel Discussion
|
| 16:30 |
Session IV: Regulatory Considerations |
| |
16:30-17:00
Panel: What to Expect from Regulatory Agencies, and What Could They Do?
Alexander Fleming (former FDA official)
Lucy Rose (former FDA official)
Brian Harvey (former FDA official)
Philip Home (former advisor to MHRA, EMA, NICE, FDA)
17:00-17:30
Moderated Discussion: So What? A Look Ahead to Day 2
Ed Saltzman, Founder and Executive Chairman, Defined Health, USA
|
| 17:30 |
End of Day One
|